An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line.
Hirschberg S, Ghazaani F, Ben Amor G, Pydde M, Nagel A, Germani S, Monica L, Schlör A, Bauer H, Hornung J, Voetz M, Dwai Y, Scheer B, Ringel F, Kamal-Eddin O, Harms C, Füner J, Adrian L, Pruß A, Schulze-Forster K, Hanack K, Kamhieh-Milz J.
Hirschberg S, et al. Among authors: scheer b.
Vaccines (Basel). 2023 Sep 9;11(9):1469. doi: 10.3390/vaccines11091469.
Vaccines (Basel). 2023.
PMID: 37766145
Free PMC article.